Sun Pharma Q4 Results: Profit declines 19% YoY; declares dividend of ₹5.50

Sun Pharma Q4 Results: Sun Pharmaceutical Industries reported a 19% YoY decline in Q4FY25 profit at ₹2,153.93 crore. However, total revenue rose 8% YoY to ₹12,958.84 crore, and EBITDA increased 22% to ₹3,716 crore.

Markets